Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets K Thapa, H Khan, TG Singh, A Kaur Journal of Molecular Neuroscience 71 (9), 1725-1742, 2021 | 154 | 2021 |
Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases K Thapa, H Khan, U Sharma, AK Grewal, TG Singh Life Sciences 267, 118975, 2021 | 60 | 2021 |
Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling A Sharma, H Khan, TG Singh, AK Grewal, A Najda, ... International Journal of Molecular Sciences 22 (21), 11971, 2021 | 47 | 2021 |
Sirtuin acetylation and deacetylation: a complex paradigm in neurodegenerative disease H Khan, P Tiwari, A Kaur, TG Singh Molecular Neurobiology 58, 3903-3917, 2021 | 46 | 2021 |
Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury H Khan, K Sharma, A Kumar, A Kaur, TG Singh Inflammation Research 71 (3), 277-292, 2022 | 43 | 2022 |
Therapeutic insights on ferroptosis in Parkinson's disease K Thapa, H Khan, N Kanojia, TG Singh, A Kaur, G Kaur European journal of pharmacology 930, 175133, 2022 | 41 | 2022 |
Mechanistic insight on the role of leukotriene receptors in ischemic–reperfusion injury H Khan, A Gupta, TG Singh, A Kaur Pharmacological Reports 73, 1240-1254, 2021 | 39 | 2021 |
Neuropeptides: Potential neuroprotective agents in ischemic injury P Saklani, H Khan, S Gupta, A Kaur, TG Singh Life Sciences 288, 120186, 2022 | 38 | 2022 |
Therapeutic modulation of the phosphatidylinositol 3-kinases (PI3K) pathway in cerebral ischemic injury H Khan, A Singh, K Thapa, N Garg, AK Grewal, TG Singh Brain Research 1761, 147399, 2021 | 38 | 2021 |
α-Lipoic acid, an organosulfur biomolecule a novel therapeutic agent for neurodegenerative disorders: an mechanistic perspective H Khan, TG Singh, RS Dahiya, MM Abdel-Daim Neurochemical research 47 (7), 1853-1864, 2022 | 33 | 2022 |
Pharmacological postconditioning: a molecular aspect in ischemic injury H Khan, A Kashyap, A Kaur, TG Singh Journal of Pharmacy and Pharmacology 72 (11), 1513-1527, 2020 | 32 | 2020 |
Novel targets explored in the treatment of alcohol withdrawal syndrome A Gupta, H Khan, A Kaur, TG Singh CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2021 | 30 | 2021 |
Calpain inhibitors as potential therapeutic modulators in neurodegenerative diseases H Khan, N Garg, TG Singh, A Kaur, K Thapa Neurochemical Research 47 (5), 1125-1149, 2022 | 28 | 2022 |
Mechanistic insight on autophagy modulated molecular pathways in cerebral ischemic injury: from preclinical to clinical perspective P Kalra, H Khan, A Kaur, TG Singh Neurochemical Research, 1-19, 2022 | 26 | 2022 |
Intervention of neuroinflammation in the traumatic brain injury trajectory: In vivo and clinical approaches NK Prabhakar, H Khan, AK Grewal, TG Singh International Immunopharmacology 108, 108902, 2022 | 23 | 2022 |
Caspase-mediated regulation of the distinct signaling pathways and mechanisms in neuronal survival H Khan, A Bangar, AK Grewal, P Bansal, TG Singh International Immunopharmacology 110, 108951, 2022 | 22 | 2022 |
Pharmacological postconditioning by protocatechuic acid attenuates brain injury in ischemia–reperfusion (I/R) mice model: implications of nuclear factor erythroid-2-related … H Khan, AK Grewal, TG Singh Neuroscience 491, 23-31, 2022 | 22 | 2022 |
Vitamin D as therapeutic modulator in cerebrovascular diseases: a mechanistic perspectives V Rihal, H Khan, A Kaur, TG Singh Critical reviews in food science and nutrition 63 (25), 7772-7794, 2023 | 19 | 2023 |
Therapeutic and mechanistic intervention of vitamin D in neuropsychiatric disorders V Rihal, A Kaur, TG Singh, MM Abdel-Daim Psychiatry Research 317, 114782, 2022 | 19 | 2022 |
Therapeutic implications of sonic hedgehog pathway in metabolic disorders: Novel target for effective treatment C Garg, A Kaur, TG Singh, VK Sharma, SK Singh Pharmacological Research 179, 106194, 2022 | 17 | 2022 |